Pulse.

a daily field guide to health research that matters

◆ Console

‹ Fri · 13 Nov 2026
Standard addition

Real-world effectiveness of tirzepatide in individuals with obesity: weight response, treatment-related factors and diabetes status

People using tirzepatide for obesity lose weight in routine practice, though prior exposure to related drugs reduces effectiveness in some patients.

This multicenter study followed 588 adults receiving tirzepatide in routine practice. Weight loss differed by diabetes status, and prior exposure to a related drug class was independently associated with less weight reduction.

What the study was

Study design
Retrospective multicenter cohort
Population
Adults with overweight or obesity treated with tirzepatide
Sample size
588
Category
Treatment Innovation
Maturity
Validated
Journal
Diabetes & metabolism

Why it surfaced

Real-world treatment-effect modifiers are clinically useful, but the retrospective design limits causal inference.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.